2000
DOI: 10.1016/s0893-133x(99)00088-3
|View full text |Cite
|
Sign up to set email alerts
|

Intravenous Scopolamine Is Potently Self-Administered in Drug-Naive Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0
1

Year Published

2000
2000
2014
2014

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 17 publications
0
6
0
1
Order By: Relevance
“…In general, these studies found that ICSS was depressed by mAChR agonists (arecoline and pilocarpine) and the AChE inhibitor physostigmine, but facilitated by the mAChR antagonist scopolamine (Olds and Domino, 1969;Olds, 1972;Druhan et al, 1989). The facilitation of ICSS by scopolamine parallels evidence for reinforcing effects of scopolamine in drug self-administration procedures in rats and mice (Glick and Guido, 1982;Rasmussen and Fink-Jensen, 2000). Other studies have examined effects of centrally administered mAChR ligands, and in contrast to effects of systemic administration, both scopolamine and the other mAChR antagonist atropine depressed ICSS (Kofman and Yeomans, 1988).…”
Section: Cholinergic Drugsmentioning
confidence: 83%
“…In general, these studies found that ICSS was depressed by mAChR agonists (arecoline and pilocarpine) and the AChE inhibitor physostigmine, but facilitated by the mAChR antagonist scopolamine (Olds and Domino, 1969;Olds, 1972;Druhan et al, 1989). The facilitation of ICSS by scopolamine parallels evidence for reinforcing effects of scopolamine in drug self-administration procedures in rats and mice (Glick and Guido, 1982;Rasmussen and Fink-Jensen, 2000). Other studies have examined effects of centrally administered mAChR ligands, and in contrast to effects of systemic administration, both scopolamine and the other mAChR antagonist atropine depressed ICSS (Kofman and Yeomans, 1988).…”
Section: Cholinergic Drugsmentioning
confidence: 83%
“…In addition, our failure to detect changes in performance on saline injection days between atropine exposures suggest that such effects were small at best, but such effects cannot be rule out. However, it is not unusual to observe an inverted U-shaped function of learning or performance effects with muscarinic anticholinergic drugs such as atropine and scopolamine (e.g., Carnicella et al, 2005a, 2005b; Rasmussen & Fink-Jensen, 2000; Stewart & Blain, 1975), and such effects have been attributed to drug effects on cortical arousal measured by EEG and concomitant cognitive arousal that align with the Yerkes-Dodson law (Graef, Schoknecht, Sabri, & Hegerl, 2011). …”
Section: Discussionmentioning
confidence: 99%
“…Recently, studies have been published by several groups employing an acute mouse model where animals are tested in pairs using a contingent and a yoked control mouse, which enables rapid assessment of the reinforcing properties of a compound. Although this acute model is thought to assess the initiation rather than the chronic maintenance of drug-taking behavior, it was demonstrated that drug-naïve mice acutely self-administer the same drugs that humans abuse, such as cocaine (Kuzmin et al, 1992; Kuzmin et al, 1996c; Kuzmin et al, 1996d; Kuzmin and Johansson, 2000; Kuzmin et al, 2000; Rasmussen et al, 2000; Blokhina et al, 2005; Lesscher et al, 2005), morphine (Kuzmin et al, 1996a; Kuzmin et al, 1997), amphetamine (Cossu et al, 2001), cannabinoids (Martellotta et al, 1998a), γ-hydroxybutyric acid (Martellotta et al, 1998c; Fattore et al, 2000; Fattore et al, 2001), scopolamine (Rasmussen and Fink-Jensen, 2000), and nicotine (Martellotta et al, 1995; Rasmussen and Swedberg, 1998; Fattore et al, 2002; Paterson et al, 2003). These studies demonstrated that drug-naïve mice exhibit SA behavior similar to rats chronically trained under the same schedule of reinforcement (FR1) and using the same operant response, i.e.…”
Section: Introductionmentioning
confidence: 99%